Skip to main content

HubXchange

HubXChange logo
 

CNS Discovery Xchange - Boston 2026

Page Banner 1

1-featuredimage

Welcome to hubXchange's CNS Discovery Xchange Boston 2026.

This event brings together senior-level scientists and executives from the pharmaceutical and biotech sectors to tackle key challenges in Target Discovery, Disease Models, Novel Modalities, and Blood Brain Barrier.

Attendees can engage in roundtable discussions, pre-booked 1:1 meetings, presentations, and networking sessions with top industry experts, to foster collaboration and find innovative solutions to accelerate CNS Discovery.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking.

Boston | Tuesday 5th May 2026 | 08:00am - 05:45pm

VIEW AGENDA    REGISTER FOR FREE    OUR PARTNERS    EVENT INFORMATION

Why choose hubXchange?

 

FULL AGENDA

Click the topic titles to find out more!

Loading
08:00
  1. Registration
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
08:30
  1. Opening Address & Keynote Presentation:
    60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
09:05
  1. Target Discovery
    Navigating pathway redundancy to unlock novel CNS targets
    60 mins
    • Target Discovery
    Daniel Klamer
    Daniel Klamer, Vice President (Business Development & Scientific Strategy) - Anavex Life Sciences
  2. Disease Models
    Overcoming the translational gap between preclinical CNS models and human outcomes [Topic TBC]
    60 mins
    • Disease Models
    Lorelai Stoica
    Lorelai Stoica, Lorelai Stoica, Executive Director, Nonclinical Research, Ultragenyx - Ultragenyx
  3. Novel Modalities
    Balancing innovation in new modalities with neurotoxicity and safety concerns
    60 mins
    • Novel Modalities
    Asli Sahin
    Asli Sahin, Director, S&E Neuroscience - AbbVie
  4. Blood Brain Barrier
    Breaking through the blood–brain barrier to enable effective CNS therapies [Topic TBC]
    60 mins
    • Blood Brain Barrier
    Larry Brown
    Larry Brown, Executive Vice President & Chief Scientific Officer - Noveome
10:10
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
10:40
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
11:10
  1. Morning Refreshments
    10 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
11:20
  1. Target Discovery
    Sponsor Led Roundtable: Bridging omics discoveries with functional target validation in the brain
    60 mins
    • Target Discovery
  2. Disease Models
    Sponsor Led Roundtable: Capturing human neural circuitry complexity in disease modeling
    60 mins
    • Disease Models
  3. Novel Modalities
    Sponsor Led Roundtable: Pursuing precision medicine in heterogeneous CNS patient populations
    60 mins
    • Novel Modalities
     
  4. Blood Brain Barrier
    Sponsor Led Roundtable: Optimizing CNS penetration while minimizing systemic toxicity
    60 mins
    • Blood Brain Barrier
12:20
  1. Networking Lunch
    60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
13:25
  1. Spotlight Presentation:
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
14:00
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
14:30
  1. 1-2-1 Meetings / Networking Break
    30 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
15:05
  1. Target Discovery
    Poster Presentation: Addressing disease heterogeneity in neurodegenerative and psychiatric target discovery
    30 mins
    • Target Discovery
  2. Disease Models
    Poster Presentation: Tackling species differences to improve neurobiological model accuracy
    30 mins
    • Disease Models
  3. Novel Modalities
    Poster Presentation: Integrating novel modalities with existing CNS treatment paradigms
    30 mins
    • Novel Modalities
  4. Blood Brain Barrier
    Poster Presentation: Evaluating the translational impact of nanotechnology and advanced carriers
    30 mins
    • Blood Brain Barrier
15:35
  1. Afternoon Refreshments
    10 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier
15:45
  1. Target Discovery
    Innovating approaches to measure target engagement in the CNS
    60 mins
    • Target Discovery
  2. Disease Models
    Closing the biomarker gap for reliable CNS target engagement readouts
    60 mins
    • Disease Models
  3. Novel Modalities
    Applying AI-driven chemistry to accelerate novel modality design
    60 mins
    • Novel Modalities
  4. Blood Brain Barrier
    Developing robust methods to track drug distribution and target engagement beyond the BBB [Topic TBC]
    60 mins
    • Blood Brain Barrier
    Susan Rosenbaum
    Susan Rosenbaum, Founder, Chairman & CEO - Lauren Sciences
16:45
  1. Evening Drinks Reception
    60 mins
    • Target Discovery
    • Disease Models
    • Novel Modalities
    • Blood Brain Barrier

EVENT INFORMATION

3-featuredimage

DATES

Boston
5 May 2026
Tuesday 5th May 2026

 

Hilton Woburn Hotel

VENUE

Hilton Munich Airport Hotel

2 Forbes Rd
Woburn
MA 01801
United States

MAP

EVENT PARTNERS

4-featuredimage

EVENT PARTNERS

Loading

REGISTRATION FORM - Register for free!

6-featuredimage

Complimentary Registration is only available for Senior Scientists & above, in Pharma & Bio Tech, with an active drug pipeline.
 

For Service Providers, please click here.

Search